Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

New findings from the EXERT study reveal that both low and moderate-high intensity exercise may help preserve cognitive function in older adults with mild memory problems, a major risk factor for ...

Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

The strategy was also overweight healthcare and industrials thanks to pharmaceutical picks such as Novo Nordisk NVO and aerospace companies like Airbus. The strategy's focus on multinational ...